Functional repair of p53 mutation in colorectal cancer cells using trans-splicing.

Abstract excerpt

Mutation in the p53 gene is arguably the most frequent type of gene-specific alterations in human cancers. Current p53-based gene therapy contains the administration of wt-p53 or the suppression of mutant p53 expression in p53-defective cancer cells. . We hypothesized that trans-splicing could be exploited as a tool for the correction of mutant p53 transcripts in p53-mutated human colorectal cancer (CRC) cells....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenoviridae
• Share to Cell Cycle Checkpoints